2007
DOI: 10.3748/wjg.v13.i48.6498
|View full text |Cite
|
Sign up to set email alerts
|

Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice

Abstract: AIM:To investigate the effect of arsenic trioxide (As2O3) on expression of vascular endothelial growth factor receptor-1 (VEGFR-1, Flt-1) and VEGFR-2 (KDR) in human gastric tumor cells and proliferation of vascular endothelial cells. METHODS:The solid tumor model was formed in nude mice with the gastric cancer cell line SGC-7901. The animals were treated with As2O3. Microvessel density (MVD) and expression of Flt-1 and KDR were detected by immunofluorescence laser confocal microscopy. SGC-7901 cells were treat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 28 publications
0
7
0
Order By: Relevance
“…The current results suggest that cleavage of VEGFR-2 by MMPs occurs in the same mesenteric tissue, which in the SHR is associated with microvascular rarefac- tion, dysfunction, and endothelial apoptosis. Cleavage of the extracellular domain reduces the ability of the cell to bind VEGF agonists and may be one of the reasons for the enhanced apoptosis in the SHR endothelium [10,12,23,25]. The functional effect of attenuated VEGFR-2 signaling on vessel loss is supported by observation of reduced VEGFR-2 protein levels being associated with impaired angiogenesis in the SHR [24].…”
Section: Discussionmentioning
confidence: 99%
“…The current results suggest that cleavage of VEGFR-2 by MMPs occurs in the same mesenteric tissue, which in the SHR is associated with microvascular rarefac- tion, dysfunction, and endothelial apoptosis. Cleavage of the extracellular domain reduces the ability of the cell to bind VEGF agonists and may be one of the reasons for the enhanced apoptosis in the SHR endothelium [10,12,23,25]. The functional effect of attenuated VEGFR-2 signaling on vessel loss is supported by observation of reduced VEGFR-2 protein levels being associated with impaired angiogenesis in the SHR [24].…”
Section: Discussionmentioning
confidence: 99%
“…ATO is a chemotherapy drug and exhibits low toxicity when used in the treatment of APL [2]. ATO has been shown to induce anti-lymphangiogenic activity in a mouse model of gastric cancer by various mechanisms, including the downregulation of pro-lymphangiogenic factors such as VEGFR-3 and VEGF-C in cancer cells [19]. In addition, it has been demonstrated that ATO impairs angiogenesis in vitro and in vivo [16,28,29].…”
Section: Discussionmentioning
confidence: 99%
“…Thus, targeting tumor lymphangiogenesis may provide a promising approach to treat cancer metastasis. The first evidence in a gastric cancer model revealed that As 2 O 3 may inhibit lymphangiogenesis by suppressing the expression of VEGF-C and VEGFR-3 in gastric cancer cells [19]. Based on these findings, we investigated the anti-lymphangiogenic effects of ATO in primary human lymphatic endothelial cells.…”
Section: Introductionmentioning
confidence: 99%
“…The cell suspension was mixed in 150 mL DMSO and the absorbance at 492 nm was measured in a microplate reader (Multiskan EX Microplate Photometer, model 355, Thermo-Labsystems, Shanghai, China). The percentage of viable cells was calculated as described [21]. Cell viability was ~98% in the absence or presence of ATO (not shown).…”
Section: Cell Number and Viabilitymentioning
confidence: 99%
“…t = 0 h), and e is 2.7182. The K values were expressed as the number of cells x10 3 per cm 2 of cell culture surface per hour [4,21]. Doubling time (Dt) for cell growth was derived from 0.6932/K and was expressed in hours.…”
Section: Cell Number and Viabilitymentioning
confidence: 99%